Friday, August 17, 2012

Former S.F. developer Rosenberg steps up his Alzheimer's fight

Douglas Rosenberg.
Douglas Rosenberg is expanding his war against Alzheimer’s disease. Just 19 months after Rosenberg invested the first $3.5 million of $10 million he hopes to raise for Dale Bredesen’s research at the Buck Institute for Research on Aging, the lab is on the cusp of leapfrogging a potential Alzheimer’s drug into an overseas trial this fall. Meanwhile, the 54-year-old former San Francisco real estate developer is pursuing other initiatives. He is forming a company around a combination of common supplements that research suggests could stave off Alzheimer’s. He has pulled together a group of researchers to share ideas and data. He is reaching out to other philanthropists, and he is weighing an investment in a drug-development company spun out of the work of Stanford University’s Frank Longo.

No comments:

Post a Comment